Related Experiment Video
Updated: Jun 28, 2025

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
Similarity assessment by multivariate statistics method based on the distance between biosimilar and originator
Jian Xu1, Zhihui Shao2, Xiaoxiong Han3
1State Key Laboratory of Bioreactor Engineering, Shanghai Collaborative Innovation Center for Biomanufacturing Technology, East China University of Science and Technology, 130 Mei Long Road, Shanghai, 200237, China.
A new data analysis method assesses antibody glycosylation similarity for biosimilar development. Higher GlcNAc levels in cell culture media improved glycan similarity to the reference product.
Area of Science:
- Biopharmaceutical Development
- Analytical Chemistry
- Biotechnology
Background:
- Biosimilar products, or follow-on biologics, offer lower-cost alternatives to originator biologics.
- Assessing the similarity of critical quality attributes, such as glycosylation patterns, is crucial for biosimilarity.
- Optimization of cell culture conditions is essential for producing biosimilar candidates with comparable characteristics.
Purpose of the Study:
- To propose a multivariate data analysis method for evaluating glycosylation pattern similarity between antibody candidates and a reference.
- To demonstrate the application of this method in optimizing cell culture conditions for biosimilar development.
- To identify specific media components that influence glycan similarity.
Main Methods:
- Utilized JMP software for multivariate data analysis.
- Developed a specific distance metric to quantify glycoform similarity.
- Conducted optimization experiments varying cell culture media components, including N-acetylglucosamine (GlcNAc).
Main Results:
- The proposed data analysis method successfully generated a distance metric indicating glycoform similarity.
- Increased concentration of GlcNAc in the basal media resulted in antibody glycans more similar to the reference.
- The method is applicable to assessing other physicochemical and functional similarities of follow-on biologics.
Conclusions:
- A robust data analysis approach can effectively assess biosimilar glycosylation similarity.
- N-acetylglucosamine (GlcNAc) supplementation is a viable strategy to enhance glycan similarity in antibody candidates.
- This methodology supports the design of experiments for optimizing cell culture and developing comparable biosimilars.
More Related Videos
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
07:35Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
Related Concept Videos
Bioequivalence: Overview
Evolutionary Relationships through Genome Comparisons
Variability: Analysis
The range is a simple measure of variability, indicating the difference between the highest and...
Analysis of Population Pharmacokinetic Data
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
One-Way ANOVA: Equal Sample Sizes
Different sample means can result in different values for the variance estimate: variance between samples. This is because the variance between samples is calculated as the product of the sample size and the variance between the...